Cracking Down on Drug Price Gouging Could Benefit Maryland Residents, State Budget
February 15, 2017
Position statement supporting Senate Bill 415 Given before the Senate Finance Committee There have been several high-profile examples in recent years of drug manufacturers sharply hiking prices for no apparent reason beyond increasing profits. These actions harm Maryland residents –